PRESS RELEASE

Q4 2022 — Press release

Q4 2022PDF · 13 pages325 KB
Page 1 of 6
UnitedHealth Group Reports 2022 Results
• 	Revenues of $324.2 Billion Grew 13% Year-Over-Year, with Double-Digit Growth at
both Optum and UnitedHealthcare
• 	Cash Flows from Operations were $26.2 Billion or 1.3x Net Income
• 	Full Year and Fourth Quarter Net Earnings were $21.18 and $5.03 Per Share
• 	Full Year and Fourth Quarter Adjusted Net Earnings were $22.19 and $5.34 Per Share
MINNETONKA, Minn. (January 13, 2023) – UnitedHealth Group (NYSE: UNH) reported full year and
fourth quarter 2022 results reflecting broad-based growth at Optum and UnitedHealthcare.
“We expect the efforts by the people of our company that led to strong performance in 2022 will define
2023 as well, especially delivering balanced growth enterprise-wide, improving support for consumers
and care providers, and investing to make high-quality care simpler, more accessible and affordable
for everyone,” said Andrew Witty, chief executive officer of UnitedHealth Group.
UnitedHealth Group affirmed the 2023 growth and performance objectives established at its November
29th Investor Conference, including revenues of $357 billion to $360 billion, net earnings of $23.15 to
$23.65 per share, adjusted net earnings of $24.40 to $24.90 per share and cash flows from operations
of $27 billion to $28 billion.

-- 1 of 13 --

Page 2 of 6
Quarterly and Annual Financial Performance
Three Months Ended 	Year Ended
December 31,
2022
December 31,
2021
September 30,
2022
December 31,
2022
December 31,
2021
Revenues 	$82.8 billion 	$73.7 billion 	$80.9 billion 	$324.2 billion 	$287.6 billion
Earnings from
Operations 	$6.9 billion 	$5.5 billion 	$7.5 billion 	$28.4 billion 	$24.0 billion
Net Margin 	5.8% 	5.5% 	6.5% 	6.2% 	6.0%
• 	UnitedHealth Group’s 2022 revenues grew $36.6 billion or 13% year-over-year to $324.2 billion
with double digit growth at both Optum and UnitedHealthcare, driven primarily by serving more
people and by serving them more comprehensively.
• 	Full year 2022 earnings from operations were $28.4 billion, an increase of 19%, with strong
contributions from Optum and UnitedHealthcare. Earnings per share grew 17% compared to
last year.
• 	The medical care ratio at 82.0% for full year 2022 and 82.8% for the fourth quarter was
consistent with the company’s recent Investor Conference outlook. Days claims payable were
49.9 in the fourth quarter compared to 46.8 a year ago and 50.8 in third quarter 2022.
Favorable medical reserve development was $620 million in the quarter.
• 	The full year 2022 operating cost ratio of 14.7% compared to 14.8% in 2021, with ongoing
productivity gains offset by business mix and continued investments in growth initiatives.
• 	Cash flows from operations for the full year were $26.2 billion or 1.3-times net income. During
2022, the company returned approximately $13 billion to shareholders through dividends and
share repurchases. Return on equity of 27.2% in 2022 reflected the company’s strong overall
growth and efficient capital structure.

-- 2 of 13 --

Page 3 of 6
UnitedHealthcare provides health care benefits globally, serving individuals and employers, and Medicare
and Medicaid beneficiaries. UnitedHealthcare is dedicated to improving the value customers and
consumers receive by improving health and wellness, enhancing the quality of care received, simplifying
the health care experience and reducing the total cost of care.
Quarterly and Annual Financial Performance
Three Months Ended 	Year Ended
December 31,
2022
December 31,
2021
September 30,
2022
December 31,
2022
December 31,
2021
Revenues 	$63.0 billion 	$56.4 billion 	$62.0 billion 	$249.7 billion 	$222.9 billion
Earnings from
Operations 	$2.9 billion 	$2.1 billion 	$3.8 billion 	$14.4 billion 	$12.0 billion
Operating
Margin
4.7% 	3.8% 	6.1% 	5.8% 	5.4%
• 	UnitedHealthcare full year revenues of $249.7 billion grew $26.8 billion or 12% year-over-year,
reflecting growth in the number of people served.
• 	Full year operating earnings were $14.4 billion compared to $12.0 billion last year, reflecting
growth in people served and continued strong medical and operating cost management.
• 	People served domestically by UnitedHealthcare grew by over 1.2 million in 2022, led by the
company’s community-based and senior offerings. The number of consumers served with
domestic commercial benefit offerings grew by 275,000 over the past nine months.

-- 3 of 13 --

Page 4 of 6
Optum’s health services businesses serve the global health care marketplace, including payers, care
providers, employers, governments, life sciences companies and consumers. Using market-leading
information, analytics and technology to yield clinical insights, Optum helps improve overall health system
performance: optimizing care quality, reducing care costs and improving the consumer experience.
Quarterly and Annual Financial Performance
Three Months Ended 	Year Ended
December 31,
2022
December 31,
2021
September 30,
2022
December 31,
2022
December 31,
2021
Revenues 	$47.9 billion 	$41.1 billion 	$46.6 billion 	$182.8 billion 	$155.6 billion
Earnings from
Operations 	$4.0 billion 	$3.4 billion 	$3.7 billion 	$14.1 billion 	$12.0 billion
Operating
Margin
8.3% 	8.3% 	7.9% 	7.7% 	7.7%
• 	Optum full year revenues of $182.8 billion grew $27.2 billion or 17% year-over-year, led by
Optum Health, and full year operating earnings increased to $14.1 billion compared to $12.0
billion last year.
• 	Optum Health revenue per consumer served increased by 29% in 2022, driven by growth in
patients served under value-based arrangements; expansion of care delivery services,
including in-home, clinic-based, ambulatory surgery, behavioral and digital; and overall
increasing acuity levels of the care that can be offered.
• 	Optum Insight’s revenue backlog increased by $7.6 billion in 2022 to $30 billion, driven by the
addition of Change Healthcare and growth in comprehensive managed services. In order to
speed improved system performance and experiences for patients and care providers, Optum
Insight is advancing its investment initiatives.
• 	Optum Rx revenue growth of 9% in 2022 reflects continued expansion of its pharmacy care
services, adding clinical value to medications, including specialty and community-based
pharmacies. Adjusted scripts grew to 1.44 billion compared to 1.37 billion last year.

-- 4 of 13 --

Page 5 of 6
About UnitedHealth Group
UnitedHealth Group (NYSE: UNH) is a health care and well-being company with a mission to help
people live healthier lives and help make the health system work better for everyone through two
distinct and complementary businesses. Optum delivers care aided by technology and data,
empowering people, partners and providers with the guidance and tools they need to achieve better
health. UnitedHealthcare offers a full range of health benefits, enabling affordable coverage,
simplifying the health care experience and delivering access to high-quality care. Visit UnitedHealth
Group at www.unitedhealthgroup.com and follow @UnitedHealthGrp on Twitter.
Earnings Conference Call
As previously announced, UnitedHealth Group will discuss the company’s results, strategy and future
outlook on a conference call with investors at 8:45 a.m. Eastern Time today. UnitedHealth Group will
host a live webcast of this conference call from the Investor Relations page of the company’s website
(www.unitedhealthgroup.com). Following the call, a webcast replay will be on the Investor Relations
page and at https://uhg.com/Replay through January 27, 2023. This earnings release and the Form 8-
K dated January 13, 2023, can also be accessed from the Investor Relations page of the company’s
website.
Non-GAAP Financial Information
This news release presents non-GAAP financial information provided as a complement to the results
provided in accordance with accounting principles generally accepted in the United States of America
(“GAAP”). A reconciliation of the non-GAAP financial information to the most directly comparable
GAAP financial measure is provided in the accompanying tables found at the end of this release.
Forward-Looking Statements
The statements, estimates, projections, guidance or outlook contained in this document include
“forward-looking” statements which are intended to take advantage of the “safe harbor” provisions of
the federal securities law. The words “believe,” “expect,” “intend,” “estimate,” “anticipate,” “forecast,”
“outlook,” “plan,” “project,” “should” and similar expressions identify forward-looking statements. These
statements may contain information about financial prospects, economic conditions and trends and
involve risks and uncertainties. Actual results could differ materially from those that management
expects, depending on the outcome of certain factors including: risks associated with public health
crises, large-scale medical emergencies and pandemics; our ability to effectively estimate, price for
and manage medical costs; new or changes in existing health care laws or regulations, or their

-- 5 of 13 --

Page 6 of 6
enforcement or application; the DOJ’s legal action relating to the risk adjustment submission matter;
our ability to maintain and achieve improvement in quality scores impacting revenue; reductions in
revenue or delays to cash flows received under government programs; changes in Medicare, the CMS
star ratings program or the application of risk adjustment data validation audits; failure to maintain
effective and efficient information systems or if our technology products do not operate as intended;
cyberattacks, other privacy/data security incidents, or our failure to comply with related regulations;
failure to protect proprietary rights to our databases, software and related products; risks and
uncertainties associated with our businesses providing pharmacy care services; competitive
pressures, including our ability to develop and deliver innovative products to health care payers and
expand access to virtual care; changes in or challenges to our public sector contract awards; failure to
develop and maintain satisfactory relationships with health care payers, physicians, hospitals and
other service providers; failure to attract, develop, retain, and manage the succession of key
employees and executives; the impact of potential changes in tax laws and regulations (including any
increase in the U.S. income tax rate applicable to corporations); failure to achieve targeted operating
cost productivity improvements; increases in costs and other liabilities associated with litigation,
government investigations, audits or reviews; failure to manage successfully our strategic alliances or
complete or receive anticipated benefits of strategic transactions; fluctuations in foreign currency
exchange rates; downgrades in our credit ratings; our investment portfolio performance; impairment of
our goodwill and intangible assets; and our ability to obtain sufficient funds from our regulated
subsidiaries or from external financings to fund our obligations, maintain our debt to total capital ratio
at targeted levels, maintain our quarterly dividend payment cycle, or continue repurchasing shares of
our common stock. This above list is not exhaustive. We discuss these matters, and certain risks that
may affect our business operations, financial condition and results of operations more fully in our filings
with the SEC, including our reports on Forms 10-K, 10-Q and 8-K. By their nature, forward-looking
statements are not guarantees of future performance or results and are subject to risks, uncertainties
and assumptions that are difficult to predict or quantify. Actual results may vary materially from
expectations expressed or implied in this document or any of our prior communications. You should not
place undue reliance on forward-looking statements, which speak only as of the date they are made.
We do not undertake to update or revise any forward-looking statements, except as required by law.
# # #
Investor Contact: 	Media Contact:
Zack Sopcak 	Matt Stearns
Senior Vice President 	Senior Vice President
952-936-7215 	202-276-0085
zack.sopcak@uhg.com 	matt.stearns@uhg.com

-- 6 of 13 --

- Condensed Consolidated Statements of Operations
- Condensed Consolidated Balance Sheets
- Condensed Consolidated Statements of Cash Flows
- Supplemental Financial Information - Businesses
- Supplemental Financial Information - Business Metrics
- Reconciliation of Non-GAAP Financial Measure
Year Ended December 31, 2022
UNITEDHEALTH GROUP
Earnings Release Schedules and Supplementary Information

-- 7 of 13 --

2022 	2021 	2022 	2021
Revenues
Premiums 	$64,700 	$57,547 	$257,157 	$226,233
Products 	9,398 	8,961 	37,424 	34,437
Services 	7,834 	6,422 	27,551 	24,603
Investment and other income 	855 	813 	2,030 	2,324
Total revenues 	82,787 	73,743 	324,162 	287,597
Operating costs
Medical costs 	53,591 	48,159 	210,842 	186,911
Operating costs 	13,009 	11,272 	47,782 	42,579
Cost of products sold 	8,314 	8,000 	33,703 	31,034
Depreciation and amortization 	982 	771 	3,400 	3,103
Total operating costs 	75,896 	68,202 	295,727 	263,627
Earnings from operations 	6,891 	5,541 	28,435 	23,970
Interest expense 	(676) 	(431) 	(2,092) 	(1,660)
Earnings before income taxes 	6,215 	5,110 	26,343 	22,310
Provision for income taxes 	(1,307) 	(919) 	(5,704) 	(4,578)
Net earnings 	4,908 	4,191 	20,639 	17,732
Earnings attributable to noncontrolling interests 	(147) 	(120) 	(519) 	(447)
Net earnings attributable to UnitedHealth Group common shareholders 	$4,761 	$4,071 	$20,120 	$17,285
Diluted earnings per share attributable to
UnitedHealth Group common shareholders 	$5.03 	$4.26 	$21.18 	$18.08
Adjusted earnings per share attributable to
UnitedHealth Group common shareholders (a) 	$5.34 	$4.48 	$22.19 	$19.02
Diluted weighted-average common shares outstanding 	947 	955 	950 	956
(a) See page 6 for a reconciliation of the non-GAAP measure
Year Ended
December 31,
Three Months Ended
December 31,
UNITEDHEALTH GROUP
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in millions, except per share data)
(unaudited)

-- 8 of 13 --

December 31, 	December 31,
2022 	2021
Assets
Cash and short-term investments 	$27,911 	$23,907
Accounts receivable, net 	17,681 	14,216
Other current assets 	23,477 	23,635
Total current assets 	69,069 	61,758
Long-term investments 	43,728 	43,114
Other long-term assets 	132,908 	107,334
Total assets 	$245,705 	$212,206
Liabilities, redeemable noncontrolling interests and equity
Medical costs payable 	$29,056 	$24,483
Short-term borrowings and current maturities of long-term debt 	3,110 	3,620
Other current liabilities 	57,071 	50,189
Total current liabilities 	89,237 	78,292
Long-term debt, less current maturities 	54,513 	42,383
Other long-term liabilities 	15,608 	15,052
Redeemable noncontrolling interests 	4,897 	1,434
Equity 	81,450 	75,045
Total liabilities, redeemable noncontrolling interests and equity 	$245,705 	$212,206
UNITEDHEALTH GROUP
CONDENSED CONSOLIDATED BALANCE SHEETS
(in millions)
(unaudited)

-- 9 of 13 --

UNITEDHEALTH GROUP
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in millions)
(unaudited)
2022 	2021
Operating Activities
Net earnings 	$20,639 	$17,732
Noncash items:
Depreciation and amortization 	3,400 	3,103
Deferred income taxes and other 	(1,004) 	(814)
Share-based compensation 	925 	800
Net changes in operating assets and liabilities 	2,246 	1,522
Cash flows from operating activities 	26,206 	22,343
Investing Activities
Purchases of investments, net of sales and maturities 	(6,837) 	(1,843)
Purchases of property, equipment and capitalized software 	(2,802) 	(2,454)
Cash paid for acquisitions, net 	(21,458) 	(4,821)
Other, net 	2,621 	(1,254)
Cash flows used for investing activities 	(28,476) 	(10,372)
Financing Activities
Common share repurchases 	(7,000) 	(5,000)
Dividends paid 	(5,991) 	(5,280)
Net change in short-term borrowings and long-term debt 	12,536 	2,481
Other, net 	4,681 	344
Cash flows from (used for) financing activities 	4,226 	(7,455)
Effect of exchange rate changes on cash and cash equivalents 	34 	(62)
Increase in cash and cash equivalents 	1,990 	4,454
Cash and cash equivalents, beginning of period 	21,375 	16,921
Cash and cash equivalents, end of period 	$23,365 	$21,375
Year Ended December 31,

-- 10 of 13 --

2022 	2021 	2022 	2021
Revenues
UnitedHealthcare 	$63,046 	$56,384 	$249,741 	$222,899
Optum 	47,868 	41,093 	182,768 	155,565
Eliminations 	(28,127) 	(23,734) 	(108,347) 	(90,867)
Total consolidated revenues 	$82,787 	$73,743 	$324,162 	$287,597
Earnings from Operations
UnitedHealthcare 	$2,932 	$2,121 	$14,379 	$11,975
Optum (a) 	3,959 	3,420 	14,056 	11,995
Total consolidated earnings from operations 	$6,891 	$5,541 	$28,435 	$23,970
Operating Margin
UnitedHealthcare 	4.7% 	3.8% 	5.8% 	5.4%
Optum 	8.3% 	8.3% 	7.7% 	7.7%
Consolidated operating margin 	8.3% 	7.5% 	8.8% 	8.3%
Revenues
UnitedHealthcare Employer & Individual - Domestic 	$16,281 	$15,355 	$63,599 	$60,023
UnitedHealthcare Employer & Individual - Global 	2,168 	2,053 	8,668 	8,345
UnitedHealthcare Employer & Individual - Total 	18,449 	17,408 	72,267 	68,368
UnitedHealthcare Medicare & Retirement 	28,051 	24,843 	113,671 	100,552
UnitedHealthcare Community & State 	16,546 	14,133 	63,803 	53,979
Optum Health 	$18,446 	$14,550 	$71,174 	$54,065
Optum Insight 	4,387 	3,251 	14,581 	12,199
Optum Rx 	25,854 	23,849 	99,773 	91,314
Optum eliminations 	(819) 	(557) 	(2,760) 	(2,013)
(a)
Year Ended
December 31,
Three Months Ended
December 31,
UNITEDHEALTH GROUP
SUPPLEMENTAL FINANCIAL INFORMATION - BUSINESSES
(in millions, except percentages)
(unaudited)
Earnings from operations for Optum for the three months and year ended December 31, 2022 included $1,692 and $6,032 for Optum Health; $895 and $3,588 for Optum Insight; and
$1,372 and $4,436 for Optum Rx, respectively. Earnings from operations for Optum for the three months and year ended December 31, 2021 included $1,229 and $4,462 for Optum
Health; $951 and $3,398 for Optum Insight; and $1,240 and $4,135 for Optum Rx, respectively.

-- 11 of 13 --

People Served 	December 31, 2022 	September 30, 2022 	December 31, 2021
Commercial - Domestic:
Risk-based 	8,045 	8,055 	7,985
Fee-based 	18,640 	18,500 	18,595
Total Commercial - Domestic 	26,685 	26,555 	26,580
Medicare Advantage 	7,105 	7,035 	6,490
Medicaid 	8,170 	8,005 	7,655
Medicare Supplement (Standardized) 	4,375 	4,370 	4,395
Total Community and Senior 	19,650 	19,410 	18,540
Total UnitedHealthcare - Domestic Medical 	46,335 	45,965 	45,120
Commerical - Global 	5,360 	5,360 	5,510
Total UnitedHealthcare - Medical 	51,695 	51,325 	50,630
Supplemental Data
Medicare Part D stand-alone 	3,295 	3,310 	3,700
December 31, 2022 	September 30, 2022 	December 31, 2021
Optum Health Consumers Served (in millions) 	102 	101 	100
Optum Insight Contract Backlog (in billions) 	$30.0 	$24.1 	$22.4
Optum Rx Quarterly Adjusted Scripts (in millions) 	370 	359 	353
Note: UnitedHealth Group served 151 million unique individuals across all businesses at December 31, 2022.
UNITEDHEALTH GROUP
SUPPLEMENTAL FINANCIAL INFORMATION - BUSINESS METRICS
UNITEDHEALTHCARE CUSTOMER PROFILE
(in thousands)
OPTUM PERFORMANCE METRICS

-- 12 of 13 --

Projected
Year Ended
December 31,
2022 	2021 	2022 	2021 	2023
GAAP net earnings attributable to UnitedHealth Group common shareholders 	$4,761 	$4,071 	$20,120 	$17,285 	$21,700 - $22,300
Intangible amortization 	396 	280 	1,292 	1,184 	~1,540
Tax effect of intangible amortization 	(98) 	(68) 	(331) 	(288) 	~(380)
Adjusted net earnings attributable to UnitedHealth Group common shareholders 	$5,059 	$4,283 	$21,081 	$18,181 	$22,850 - $23,450
GAAP diluted earnings per share 	$5.03 	$4.26 	$21.18 	$18.08 	$23.15 - $23.65
Intangible amortization per share 	0.42 	0.29 	1.36 	1.24 	~1.65
Tax effect per share of intangible amortization 	(0.11) 	(0.07) 	(0.35) 	(0.30) 	~(0.40)
Adjusted diluted earnings per share 	$5.34 	$4.48 	$22.19 	$19.02 	$24.40 - $24.90
(a)
Three Months Ended
December 31,
Adjusted net earnings per share is a non-GAAP financial measure. Non-GAAP financial measures should be considered in addition to, but not as a substitute for, or superior to, financial measures prepared in accordance with GAAP.
Adjusted net earnings per share excludes from the relevant GAAP metric, as applicable, intangible amortization and other items, if any, that do not relate to the Company's underlying business performance. Management believes that the use of adjusted net
earnings per share provides investors and management useful information about the earnings impact of acquisition-related intangible asset amortization. As amortization fluctuates based on the size and timing of the Company’s acquisition activity, management
believes this exclusion provides a more useful comparison of the Company's underlying business performance and trends from period to period. While intangible assets contribute to the Company’s revenue generation, the intangible amortization is not directly
related. Therefore, the related revenues are included in adjusted earnings per share.
Year Ended
December 31,
UNITEDHEALTH GROUP
RECONCILIATION OF NON-GAAP FINANCIAL MEASURE
(in millions, except per share data)
(unaudited)
ADJUSTED NET EARNINGS PER SHARE
(a)

-- 13 of 13 --